BrainPatch scientific team have presented the poster on using our ML pipeline for non-invasive vagus nerve stimulation

The BrainPatch scientific team with CEO Nickolai Vysokov, CSO Anna Tarasenko and science intern Maria Chigireva have presented the poster on using our Machine Learning pipeline for non-invasive vagus nerve stimulation

We caught up with Dr Michael Oberle, who is the CEO of Zurich Med Tech

At the Neuromodulation and Neuroergonomics conference we caught up with Dr. Michael Oberle, who is the CEO of Zurich Med Tech, a company behind an amazing SIm4Life simulation product.

Our work at BrainPatch has been given high praise

Our work at BrainPatch has been given high praise through being selected for oral presentation at the New York Neuroergonomics and Neuromodulation conference.

Our study is live

Our study "Determination of the Effects of Transcutaneous Auricular Vagus Nerve Stimulation on the Heart Rate Variability Using a Machine Learning Pipeline" is live!

Our research has been selected for oral presentation at the Neuroergonomics and Neuromodulation conference in New York.

We are excited to announce that our Innovate-UK funded research titled "Determination of the effects of taVNS on the Heart Rate Variability using a Machine Learning pipeline" using our auricular vagus nerve stimulation device and prototype has been selected for oral presentation at the Neuroergonomics and Neuromodulation conference in New York

We have presented the BrainPatch product to the President of Kazahstan

BrainPatch abstract got accepted for Neuroergonomics Conference & NYC Neuromodulation Conference

BrainPatch abstract on "Determination of the effects of taVNS on the Heart Rate Variability using a Machine Learning pipeline" got accepted for Neuroergonomics Conference & NYC Neuromodulation Conference.

Together with the University of Surrey we have received a grant from The British Academy

We are proud to announce that together with the University of Surrey we have received a grant from The British Academy. The project targets the issue of youth mental health.

BrainPatch has successfully joined NatWest Entrepreneur Accelerator programme

BrainPatch has successfully joined NatWest Entrepreneur Accelerator programme. Proud and excited to be a part of the January 2022 Cohort.

As the holiday season is upon us, we reflecting who have helped to shape our business.

As the holiday season is upon us, we find ourselves reflecting on the past year and those who have helped to shape our business. It’s been quite a year for us all!

Novel Brain Stimulation Approach Treats Severe Depression

Combining deep-brain stimulation with intracranial EEG can now identify stimulation patterns best suited to each patient with depression for symptoms relief.

New collection of blogs from the Oxford Health BRC AIMday

In July 2021 researchers from the Oxford Health BRC hosted an Academic Industry Meeting Day in Experimental Medicine in Psychiatry. A number of early career researchers were invited to write about the sessions they attended and their blogs have been brought together in the collection below.

The future is now! Treating Severe Depression with On-Demand Brain Stimulation

UCSF Health physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.

The Pre-Seed Plus round investment was funded by Neuromotion Ventures

London-based BrainPatch has recently closed a $0.5 million funding round anticipating launch of the production line. The Seed round investment was funded by Neuromotion Ventures, along with a number angel investors.

Neuro Tech startup developing new breakthrough solutions

BrainPatch Limited, British Neuro Tech startup developing new breakthrough solutions for brain-computer interfaces and a recipient of Innovate UK and European Union Horizon 2020 Program grants, has successfully completed Seed Plus investment round on September 1st, 2020.

Who doesn't want to be at the cutting edge of neuroscience?

If you missed the Imperial College London Neurotechnology Symposium, it was full of mind-blowing research from fundamental research using artificial brains to study neurological effects of Covid-19 to updates from a $500+ million-worth company using your neural signals to control computers.